Issued Patents All Time
Showing 1–6 of 6 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12161724 | Compositions and methods related to tumor activated antibodies targeting EGFR and effector cell antigens | David CAMPBELL, Ramesh Bhatt | 2024-12-10 |
| 12152026 | Transglutaminase 2 (TG2) inhibitors | David Campbell, Justin Chapman, Mui Cheung, Sergio G. Duron | 2024-11-26 |
| 11555078 | Compositions and methods related to tumor activated antibodies targeting PSMA and effector cell antigens | David CAMPBELL | 2023-01-17 |
| 11548892 | Transglutaminase 2 (TG2) inhibitors | David Campbell, Justin Chapman, Sergio G. Duron | 2023-01-10 |
| 11512113 | Cleavable linker compositions and methods | David CAMPBELL | 2022-11-29 |
| 10010541 | Modulation of tissue transglutaminase activation in disease | Chaitan Khosla, Cornelius Kloeck | 2018-07-03 |